Michael Kolodziej M.D.

Michael Kolodziej M.D. is the National Medical Director, Managed Care Strategy, Flatiron. Dr. Kolodziej attended college and medical school at Washington University in St. Louis where he was Phi Beta Kappa and Alpha Omega Alpha. He completed internal medicine and hematology-oncology training at the University of Pennsylvania in Philadelphia. After completing training, Dr. Kolodziej joined the faculty at the University of Oklahoma School of Medicine where he was an associate professor. He joined New York Oncology in the winter of 1998, and was a partner in the practice until December 2012. He was an active member of the US Oncology Pharmacy and Therapeutics committee, on the executive committee from 2002-2011, and chairman from 2004-2011. He served as Medical Director for Oncology Services for US Oncology from 2007-2011. In this role, he helped direct the implementation of the USON clinical pathways initiative, the integration of the USON EMR into this program, and the development of the USON disease management and advanced care planning programs, now known as Innovent Oncology. He has published several manuscripts and given several presentations on oncology care delivery and reimbursement reform, use of evidence based treatment to enhance value, and personalized medicine. Dr. Kolodziej joined Aetna in January, 2013 as National Medical Director, Oncology Solutions. He directed Aetna’s oncology delivery reform pilots including the Aetna Oncology Medical Home and condition analysis. He joined Flatiron in July, 2016. He is a Fellow of the American College of Physicians. Dr. Kolodziej is married to Dr. Regina Resta, also a medical oncologist with New York Oncology Hematology, and they have two children, Peter (22) and Katherine (20).